Latest Revenue Growth News

ReNerve Limited has secured broader regulatory approval in Hong Kong for its NervAlign® Nerve Cuff, enabling access to both public and private hospitals and validating the device’s clinical benefits through independent review.

Super Retail Group has reported a record 13.1% sales growth in the first half of FY26, with normalised profit before tax expected between $172 million and $175 million despite margin challenges and weather impacts.

EBR Systems reported a doubling of WiSE System implants in Q4 FY2025 alongside the launch of key clinical studies and preliminary revenue guidance, signalling strong commercial and clinical momentum.

Mesoblast Limited reports a 60% jump in Ryoncil sales for the December quarter, underpinned by a new $125 million financing facility that strengthens its balance sheet and strategic flexibility.

Codan Limited has reported a strong first-half FY26 trading update, with revenue up 29% and underlying net profit after tax soaring 52%, driven by robust metal detection and communications segments.

FlexiRoam has secured a key partnership to provide AI-enhanced connectivity for Malaysia’s national welfare initiative, supporting over 8 million recipients and marking a strategic step into mission-critical government infrastructure.

CurveBeam AI has received official Chinese regulatory approval for a strategic $10 million investment from WEGO Orthopaedics, marking a major step in its expansion into Greater China. The initial $4 million tranche at a premium share price is expected imminently, underpinning a decade-long commercialisation deal.

Orthocell has reported a record $3.2 million in quarterly revenue, marking its seventh consecutive quarter of growth, driven by strong sales of its Remplir™ nerve repair product in Australia and early traction in the US market.

Carbonxt Group Limited has raised $600,000 through a share placement to fund working capital and increase its ownership in New Carbon Processing, LLC to 46.7%. The move supports progress at New Carbon’s Kentucky facility as it nears commissioning.

Civmec Limited has landed a series of new contracts and extensions worth more than A$400 million, including a significant package with BHP for Port Hedland’s Port Debottlenecking Project 2 and key works supporting Fortescue’s decarbonisation efforts.

Sprintex Limited has landed its largest-ever €15.6 million order for ZLD-UP® manure processing systems, marking a pivotal shift from evaluation to commercial deployment across Europe. This multi-year contract sets the stage for substantial revenue growth and a path to profitability in FY26.

Memphasys has secured CE Mark approval for its Felix™ sperm selection system, enabling full commercial rollout across Europe and activating multi-year contracts worth over A$1.3 million. This milestone signals the company’s transition into a revenue-scaling phase with global growth ambitions.